Published in AIDS on October 01, 1988
Prostitution and risk of HIV: female prostitutes in London. BMJ (1993) 6.06
HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health (2000) 2.74
Increasing risk behaviour and high levels of undiagnosed HIV infection in a community sample of homosexual men. Sex Transm Infect (2004) 2.06
Prevalence of HIV infection in provincial prisons in British Columbia. CMAJ (1994) 1.96
Prevalence of HIV infection among ex-prisoners in England. BMJ (1992) 1.61
Serological diagnosis of HIV infection using oral fluid samples. Bull World Health Organ (1994) 1.49
Immunoglobulin G antibody capture enzyme-linked immunosorbent assay: a versatile assay for detection of anti-human immunodeficiency virus type 1 and 2 antibodies in body fluids. J Clin Microbiol (1992) 1.34
Detection of specific antibodies in gingival crevicular transudate by enzyme-linked immunosorbent assay for diagnosis of human immunodeficiency virus type 1 infection. J Clin Microbiol (1992) 1.08
Detection of human immunodeficiency virus antibodies in oral fluids. Clin Diagn Lab Immunol (1998) 1.06
The testing of saliva samples for HIV-1 antibodies: reliability in a non-clinic setting. Genitourin Med (1993) 0.95
Detection of salivary antibodies in cats infected with feline immunodeficiency virus. J Clin Microbiol (1992) 0.88
HIV-1 seroprevalence and risk behaviors in an urban African-American community cohort. Am J Public Health (1993) 0.88
Human immunodeficiency virus antibody testing by enzyme-linked fluorescent and western blot assays using serum, gingival-crevicular transudate, and urine samples. J Clin Microbiol (1999) 0.84
Detection of hepatitis C virus antibodies in oral fluid specimens for prevalence studies. Eur J Clin Microbiol Infect Dis (2007) 0.79
Validation of a modified commercial enzyme-linked immunoassay for detection of human immunodeficiency virus type 1 immunoglobulin G antibodies in saliva. Clin Diagn Lab Immunol (2001) 0.78
Salivary testing for HIV infection. BMJ (1992) 0.75
NeuN, a neuronal specific nuclear protein in vertebrates. Development (1992) 10.82
Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet (1983) 4.41
Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ (2000) 4.31
Undescribed toxin in pseudomembranous colitis. Br Med J (1977) 4.31
Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health (2000) 4.25
Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg (Lond) (1983) 4.13
Rubella antibody measured by radial haemolysis. Characteristics and performance of a simple screening method for use in diagnostic laboratories. J Hyg (Lond) (1980) 4.13
Sensitive assays for viral antibodies in saliva: an alternative to tests on serum. Lancet (1987) 3.91
Human parvovirus arthropathy. Lancet (1985) 3.76
Determination of the thermal offset of the Eppley precision spectral pyranometer. Appl Opt (2001) 3.46
Antibody capture radioimmunoassay for anti-rubella IgM. J Hyg (Lond) (1981) 3.38
A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature (1983) 3.02
Detection of measles, mumps, and rubella antibodies in saliva using antibody capture radioimmunoassay. J Med Virol (1993) 2.85
Role of viruses in febrile convulsions. Arch Dis Child (1979) 2.72
The wrinkled-seed character of pea described by Mendel is caused by a transposon-like insertion in a gene encoding starch-branching enzyme. Cell (1990) 2.71
Preventing Rh immunisation. BMJ (1994) 2.70
Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill (2008) 2.66
The Arabidopsis sex1 mutant is defective in the R1 protein, a general regulator of starch degradation in plants, and not in the chloroplast hexose transporter. Plant Cell (2001) 2.63
Population dynamics of fox rabies in Europe. Nature (1981) 2.59
Poor hepatitis B vaccine coverage in injecting drug users: England, 1995 and 1996. Commun Dis Public Health (1999) 2.55
Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey. BMJ (2001) 2.53
Risk behaviour, anti-HIV and anti-hepatitis B core prevalence in clinic and non-clinic samples of gay men in England, 1991-1992. AIDS (1993) 2.50
Starch biosynthesis. Plant Cell (1995) 2.46
Limbic abnormalities in affective processing by criminal psychopaths as revealed by functional magnetic resonance imaging. Biol Psychiatry (2001) 2.35
Event-related fMRI study of response inhibition. Hum Brain Mapp (2001) 2.33
A mutant of Arabidopsis lacking a chloroplastic isoamylase accumulates both starch and phytoglycogen. Plant Cell (1998) 2.32
A critical role for disproportionating enzyme in starch breakdown is revealed by a knock-out mutation in Arabidopsis. Plant J (2001) 2.26
H(2)(15)O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans. Magn Reson Med (2000) 2.20
Preliminary report: accurate assays for anti-HIV in urine. Lancet (1990) 2.17
Prevalence of HIV infection in patients attending an inner city accident and emergency department. BMJ (1994) 2.15
Sexual lifestyle and clinical findings related to HTLV-III/LAV status in homosexual men. Genitourin Med (1986) 2.14
Novel assay for the detection of immunoglobulin G antihuman immunodeficiency virus in untreated saliva and urine. J Med Virol (1993) 2.11
A starch-accumulating mutant of Arabidopsis thaliana deficient in a chloroplastic starch-hydrolysing enzyme. Plant J (1998) 2.11
Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London. BMJ (1993) 2.07
Increasing risk behaviour and high levels of undiagnosed HIV infection in a community sample of homosexual men. Sex Transm Infect (2004) 2.06
Febrile illness due to a parvovirus. Br Med J (1980) 2.05
At least three different RNA polymerase holoenzymes direct transcription of the agarase gene (dagA) of Streptomyces coelicolor A3(2). Cell (1988) 2.04
Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities. Neurology (1994) 2.03
Sir proteins, Rif proteins, and Cdc13p bind Saccharomyces telomeres in vivo. Mol Cell Biol (1998) 2.00
Which anti-HTLV III/LAV assays for screening and confirmatory testing? Lancet (1985) 1.94
New hepatitis B vaccines. Br Med J (Clin Res Ed) (1985) 1.93
Biochemical and molecular characterization of a novel starch synthase from potato tubers. Plant J (1995) 1.91
The diverse role of selenium within selenoproteins: a review. J Am Diet Assoc (1999) 1.89
The major form of ADP-glucose pyrophosphorylase in maize endosperm is extra-plastidial. Plant Physiol (1996) 1.87
The 80th year of fifth disease. Br Med J (Clin Res Ed) (1984) 1.86
A year's experience of the rotavirus syndrome and its association with respiratory illness. Arch Dis Child (1979) 1.85
Diagnosis of hepatitis A and B by testing saliva. J Med Virol (1989) 1.82
Recent trends in HIV and other STIs in the United Kingdom: data to the end of 2002. Sex Transm Infect (2004) 1.79
Liver disease and common-bile-duct stenosis in cystic fibrosis. N Engl J Med (1988) 1.79
Characterization of a virus that causes transient aplastic crisis. J Clin Invest (1984) 1.78
Human serum "parvovirus": a specific cause of aplastic crisis in children with hereditary spherocytosis. J Pediatr (1983) 1.77
The clinical significance of blood group antibodies. Transfus Med (2002) 1.76
Identification of the major starch synthase in the soluble fraction of potato tubers. Plant Cell (1996) 1.75
Are many women immunized against rubella unnecessarily? J Hyg (Lond) (1981) 1.75
Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol (2001) 1.70
Mutations in the gene encoding starch synthase II profoundly alter amylopectin structure in pea embryos. Plant Cell (1998) 1.69
Starch branching enzymes belonging to distinct enzyme families are differentially expressed during pea embryo development. Plant J (1995) 1.68
Implications for HIV testing policy derived from combining data on voluntary confidential testing with viral sequences and serological analyses. Sex Transm Infect (2008) 1.66
Expression of gastrin in developing gastric adenocarcinoma. Br J Surg (2001) 1.65
Comparison of radioimmunoassay and counter-immunoelectrophoresis for the detection of antibody to hepatitis B core antigen. J Virol Methods (1981) 1.65
The influence of cobalt on pine disease in sheep. Biochem J (1938) 1.64
Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes. J Clin Microbiol (2006) 1.64
Complete cartilage-ring tracheal stenosis associated with anomalous left pulmonary artery: the ring-sling complex. Radiology (1984) 1.64
An epidemiological study of snake bite envenomation in Papua New Guinea. Med J Aust (1991) 1.62
The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. I. Clinical effects. J Rheumatol (1988) 1.60
Determinants of HIV disease progression: six-year longitudinal study in the Edinburgh haemophilia/HIV cohort. Lancet (1991) 1.58
Trends in female sexual behaviour and sexually transmitted diseases in London, 1982-1992. Genitourin Med (1995) 1.57
An indirect haemolysis test (IHLT) for bovine brucellosis. Aust Vet J (1976) 1.57
Development of an enzyme-linked immunosorbent assay (ELISA) for hepatitis B e antigen and antibody. J Virol Methods (1981) 1.57
A cytosolic ADP-glucose pyrophosphorylase is a feature of graminaceous endosperms, but not of other starch-storing organs. Plant Physiol (2001) 1.53
Incidence of HIV infection in homosexual men in London, 1988-94. BMJ (1995) 1.52
Foreign bodies in urinary bladder. Urology (1973) 1.52
The value of routine peroperative cholangiography--a report of 4000 cholecystectomies. Br J Surg (1982) 1.52
Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol (1986) 1.51
Sero-immunity to poliovirus in children and young women: England 1972-4. J Hyg (Lond) (1975) 1.51
Digestion of haemoglobin by schistosomes: 35 years on. Parasitol Today (1995) 1.50
Human parvovirus and the fetus. Lancet (1985) 1.50
Prevalence of antibody to human T lymphotropic virus type III by risk group and area, United Kingdom 1978-84. Br Med J (Clin Res Ed) (1985) 1.50
Rational programme for screening travellers for antibodies to hepatitis A virus. Lancet (1988) 1.50
An immunoglobulin G capture assay (GACRIA) for anti-HTLV III/LAV and its use as a confirmatory test. J Med Virol (1986) 1.48
Allergens in Hymenoptera venoms. XXIII. Venom content of imported fire ant whole body extracts. Ann Allergy (1991) 1.48
Hepatitis A in the traveller. Lancet (1983) 1.48
Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med (2002) 1.47
Spurious malarial antibodies in HIV infection. Lancet (1992) 1.46
Prevalence of anti-HTLV-III in UK risk groups 1984/85. Lancet (1986) 1.45
Experimental otitis media in gerbils and chinchillas with Streptococcus pneumoniae, Haemophilus influenzae, and other aerobic and anaerobic bacteria. Infect Immun (1982) 1.45
The coactivation of antagonist muscles. Can J Physiol Pharmacol (1981) 1.44
Soluble isoforms of starch synthase and starch-branching enzyme also occur within starch granules in developing pea embryos. Plant J (1993) 1.44
Severity of overdose after restriction of paracetamol availability: retrospective study. BMJ (2000) 1.43
Hypothesis: the aplastic crisis of hereditary spherocytosis is due to a single transmissible agent. J Clin Pathol (1983) 1.41
A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function. Neurotoxicol Teratol (2001) 1.40
Evaluation of needle exchange in central London: behaviour change and anti-HIV status over one year. AIDS (1989) 1.39
Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working? Am J Public Health (2001) 1.39